ICON

Yahoo Finance • 16 days ago

Seth Klarman's Baupost takes stake in Union Pacific, exits ViaSat, among Q3 trades

[Allen & Co. Holds Its Annual Sun Valley Conference In Idaho] Drew Angerer Baupost acquired new stakes in Union Pacific (UNP [https://seekingalpha.com/symbol/UNP]), boosted holdings in Restaurant Brands (QSR [https://seekingalpha.com/symb... Full story

Yahoo Finance • 16 days ago

ICON Public Limited Company (ICLR) Soared on Robust Performance

ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In an environment of shifting monetary policy, stabiliz... Full story

Yahoo Finance • 3 months ago

Jefferies Downgrades ICON Public Limited (ICLR) to Hold From Buy

ICON Public Limited Company (NASDAQ:ICLR) is one of the best cheap stocks to buy for beginners. On September 9, Jefferies analyst David Windley downgraded ICON Public Limited Company (NASDAQ:ICLR) to Hold from Buy, bringing the price targe... Full story

Yahoo Finance • 3 months ago

IQVIA Holdings Inc. (IQV): A Bull Case Theory

We came across a bullish thesis on IQVIA Holdings Inc. on Rebound Capital’s Substack. In this article, we will summarize the bulls’ thesis on IQV. IQVIA Holdings Inc.'s share was trading at $191.15 as of August 22nd. IQV’s trailing and for... Full story

Yahoo Finance • 3 months ago

Can AI make clinical trials better?

Investing.com -- Clinical trials are notorious for being expensive and slow, with rising costs and declining efficiency. According to Bernstein, industry R&D spending grew 44% between 2012 and 2022, while the number of novel drug approvals... Full story

Yahoo Finance • 3 months ago

Earnings call transcript: ICON plc beats Q2 2025 earnings expectations

ICON plc reported better-than-expected earnings for the second quarter of 2025, with earnings per share (EPS) of $3.26, surpassing the forecast of $3.19. This positive surprise, combined with revenue exceeding projections, led to a signifi... Full story

Yahoo Finance • 3 months ago

ICON PLC (NASDAQ:ICLR) Presents a Compelling Value Investment Opportunity with Strong Fundamentals

ICON PLC (NASDAQ:ICLR [https://www.chartmill.com/stock/quote/ICLR]) has been recognized using a "Decent Value" screening method, focusing on stocks with favorable valuation metrics alongside steady fundamentals in growth, profitability, an... Full story

Yahoo Finance • 4 months ago

ICON suspends COVID vaccine study after BARDA notice

[A woman using Covid-19 rapid self-test kit at home] Images By Tang Ming Tung ICON plc (NASDAQ:ICLR [https://seekingalpha.com/symbol/ICLR]) has announced the suspension of its COVID vaccine study following a stop work notice from BARDA.... Full story

Yahoo Finance • 4 months ago

Steven Romick's Strategic Moves: A Closer Look at Amrize Ltd's Impactful Addition

Exploring the Latest N-PORT Filing and Portfolio Adjustments Steven Romick (Trades, Portfolio) recently submitted the N-PORT filing for the second quarter of 2025, providing insights into his investment moves during this period. Steven Ro... Full story

Yahoo Finance • 4 months ago

Icon signals $8B full-year revenue midpoint as metabolic and obesity trial momentum builds

Earnings Call Insights: ICON Public Limited Company (ICLR) Q2 2025 MANAGEMENT VIEW * CEO Steven A. Cutler highlighted an 11% sequential increase in gross business awards over quarter 1, driven by wins from biotech customers and ongoing... Full story

Yahoo Finance • 4 months ago

Evercore ISI raises ICON stock price target to $240 on improving demand

Investing.com - Evercore ISI has raised its price target on ICON plc (NASDAQ:ICLR) to $240.00 from $170.00 while maintaining an Outperform rating on the clinical research organization. The new target approaches the high end of analyst esti... Full story

Yahoo Finance • 4 months ago

Icon Non-GAAP EPS of $3.26 beats by $0.08, revenue of $2.01B beats by $30M

* Icon press release [https://seekingalpha.com/pr/20175881-icon-reports-second-quarter-2025-results] (NASDAQ:ICLR [https://seekingalpha.com/symbol/ICLR]): Q2 Non-GAAP EPS of $3.26 beats by $0.08. * Revenue of $2.01B (-5.2% Y/Y) beats b... Full story

Yahoo Finance • 4 months ago

Iqvia, Medpace send CRO peers higher after Q2 beats

[Quarterly results] CharlieAJA/iStock via Getty Images Shares of contract research organizations climbed in the premarket on Tuesday after two industry leaders, IQVIA Holdings (NYSE:IQV [https://seekingalpha.com/symbol/IQV]) and Medpace H... Full story

Yahoo Finance • 5 months ago

Do You Believe in the Upside Potential of ICON PLC (ICLR)?

Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of the letter can be downloaded here. The equity portfolio returned 4.67% in the second quarter compared to 10.94% f... Full story

Yahoo Finance • 5 months ago

Validea Detailed Fundamental Analysis - ICLR

Below is Validea's guru fundamental report for ICON PLC (ICLR). Of the 22 guru strategies we follow, ICLR rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model seeks... Full story

Yahoo Finance • 5 months ago

ICON plc stock price target lowered to $187 at Truist Securities

Investing.com - Truist Securities has lowered its price target on ICON plc (NASDAQ:ICLR) to $187.00 from $190.00 while maintaining a Buy rating on the stock. Currently trading at $152.45, InvestingPro analysis suggests the stock is underva... Full story

Yahoo Finance • 5 months ago

ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability

DUBLIN, July 07, 2025--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of business awards, recognising the comp... Full story

Yahoo Finance • 5 months ago

Clearbridge Large Cap Growth Strategy Sold Its Stake in ICON Public Limited Company (ICLR)

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here. In the second quarter, the growth stocks rebo... Full story

Yahoo Finance • 5 months ago

Growth funds favor Makemytrip and SK Hynix: BofA

Investing.com -- Growth-oriented equity funds are increasingly concentrating bets in names showing strong earnings, price, and news momentum, according to Bank of America’s latest Global Fund Performance Monitor. BofA highlighted that “Gr... Full story

Yahoo Finance • 5 months ago

Will ICON PLC (ICLR) Benefit from R&D Spending?

Parnassus Investments, an investment management company, released the “Parnassus Mid Cap Growth Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The Russell Midcap Growth Index fell 7.12% in the first... Full story